A.R.T. Advisors’s Integra LifeSciences IART Stock Holding History

A.R.T. Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,963	Closed	-$277K	–	1555
2019 Q2	$277K	Sell	4,963 -7,100	-59%	-$366K	0.02%	988
2019 Q1	$672K	Buy	+12,063	New	+$614K	0.04%	640
2017 Q1	–	Sell	-16,000	Closed	-$686K	–	1549
2016 Q4	$686K	Buy	+16,000	New	+$650K	0.04%	615
2016 Q3	–	Sell	-26,644	Closed	-$1.06M	–	868
2016 Q2	$1.06M	Buy	26,644 +18,400	+223%	+$662K	0.05%	519
2016 Q1	$277K	Sell	8,244 -7,800	-49%	-$243K	0.01%	1068
2015 Q4	$543K	Buy	+16,044	New	+$501K	0.03%	828
2014 Q2	–	Sell	-31,430	Closed	-$590K	–	1399
2014 Q1	$590K	Buy	+31,430	New	+$607K	0.03%	695

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

A.R.T. Advisors's IART Position: Q3 2019 in Review

A.R.T. Advisors sold out of Integra LifeSciences (IART) in Q3 2019, closing a stake of 4,963 shares — an estimated $277K sold.

A.R.T. Advisors first reported a position in IART in Q1 2014 and held it in 7 quarters. The position peaked at $1.06M in Q2 2016. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

A.R.T. Advisors reported no remaining Integra LifeSciences position as of Q3 2019 after selling out during the quarter.
A.R.T. Advisors sold 4,963 Integra LifeSciences shares in Q3 2019, an estimated $277K.
A.R.T. Advisors first reported a position in Integra LifeSciences in Q1 2014 and held it in 7 quarters.
A.R.T. Advisors's Integra LifeSciences position peaked at $1.06M in Q2 2016.
280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.